医学
重症监护医学
抗生素耐药性
抗生素
多重耐药
抗药性
公共卫生
医疗保健
护理部
经济增长
微生物学
经济
生物
作者
Walter Y Agyeman,Aakash Bisht,Ankit Gopinath,Ameer Haider Cheema,Keyur Chaludiya,Maham Khalid,Marcellina Nwosu,Srujana Konka,Safeera Khan
出处
期刊:Cureus
[Cureus, Inc.]
日期:2022-10-05
被引量:29
摘要
Antimicrobial resistance is a major public health challenge described by the World Health Organization as one of the top 10 public health challenges worldwide. Drug-resistant microbes contribute significantly to morbidity and mortality in the hospital, especially in the critical care unit. The primary etiology of increasing antibiotic resistance is inappropriate and excessive use of antibiotics. The alarming rise of drug-resistant microbes worldwide threatens to erode our ability to treat infections with our current armamentarium of antibiotics. Unfortunately, the pace of development of new antibiotics by the pharmaceutical industry has not kept up with rising resistance to expand our options to treat microbial infections. The costs of antibiotic resistance include death and disability, extended hospital stays due to prolonged sickness, need for expensive therapies, rising healthcare expenditure, reduced productivity from time out of the workforce, and rising penury. This review sums up the common mechanisms, trends, and treatment options for hospital-acquired multidrug-resistant microbes.
科研通智能强力驱动
Strongly Powered by AbleSci AI